TABLE 1.
Parameter | Units | Model value | Literature values | References |
l-transporter (Vtrpgs, Vtrpsm, Vtrpsl) | ||||
Km | μmol/L | 64 | 64 | (41) |
Vmax | μmol/(L · h) | 400, 840, 2000 | —2 | |
VTDO | ||||
Km | μmol/L | 43 | 24.6–250 | (50, 82, 83) |
Vmax | μmol/(L · h) | 100.5 | — | |
VAFD | ||||
Km | μmol/L | 50 | 50–180 | (53, 54) |
Vmax | μmol/(L · h) | 2000 | — | |
VKMO | ||||
Km | μmol/L | 25 | 25 | (84) |
Vmax | μmol/(L · h) | 78.4 | — | |
VKYN1 | ||||
μmol/L | 240 | 240–1000 | (56, 85) | |
μmol/L | 0.88 | 0.88 | (24) | |
μmol/L | 20 | 20 | (57) | |
Vmax | μmol/(L · h) | 128.46 | — | |
VKYN2 | ||||
μmol/L | 3 | 3–45 | (57) (56, 85, 86) | |
μmol/L | 0.88 | 0.88 | (24) | |
μmol/L | 20 | 20 | (57) | |
Vmax | μmol/(L · h) | 512 | — | |
VKAT1 | ||||
μmol/L | 4700 | 2000–5000 | (87–90) | |
μmol/L | 0.85 | 0.85–7 | (24, 88) | |
Vmax | μmol/(L · h) | 1998 | — | |
VKAT2 | ||||
μmol/L | 5000 | 2000–5000 | (87–90) | |
μmol/L | 0.85 | 0.85–7 | (24, 88) | |
Vmax | μmol/(L · h) | 47,952 | — | |
VHAO | ||||
μmol/L | 10 | 2–21 | (91, 92) | |
Vmax | μmol/(L · h) | 2000 | — | |
Removal coefficients3 | ||||
d3 | h−1 | 0.2 | ||
d4 | h−1 | 3 | ||
d5 | h−1 | 240 | ||
d6 | h−1 | 8 | ||
d7 | h−1 | 6 | ||
d8 | h−1 | 40 | ||
d9 | h−1 | 0.2 | ||
Other coefficients3 | ||||
k2 | h−1 | 0.0002 | ||
k13 | h−1 | 1 | ||
k14 | h−1 | 1.2 | ||
m | h−1 | 7 |
Vmax values used in constructing the model and conducting simulations are shown (see text for explanations). AFD, aryl formamidase; HAO, 3-hydroxynalic acid oxygenase; hk, 3-hydroxykynurenine; KAT, kynurenine aminotransferase; KMO, kynurenine 3-monooxygenase; kyn, kynurenine; KYN, kynureninase; PLP, pyridoxal 5′-phosphate; TDO, tryptophan 2,3- dioxygenase; trpgs, tryptophan from gut to portal circulation; trpsl, tryptophan from portal circulation to liver; trpsm, tryptophan from peripheral circulation to muscle.
Dashes indicate that values for Vmax were not taken from the literature.
See text for Literature values.